PaulJGoodnickMDDABPN, DLFAPA

PubMed

• 234 citations
  A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.
  Mark S. George, A. John Rush, Lauren B. Marangell, Harold A. Sackeim, Stephen K. Brannan
  Biological Psychiatry. 2005-09-01
• 28 citations
  Pharmacokinetics of second generation antidepressants: bupropion.
  Paul J. Goodnick
  Psychopharmacology Bulletin. 1991-01-01
• 48 citations
  Pharmacokinetic optimisation of therapy with newer antidepressants.
  Paul J. Goodnick
  Clinical Pharmacokinetics. 1994-10-01

Journal Articles

• Anticonvulsant strategies for treating bipolar disorder: What works and what doesn’t  
  Goodnick PJ, Psychiatric Times, 1/1/2014
• Book Review of “Severe Domestic Squalor, Snowdon J, Halliday G, & Banerjee S, eds”  
  Goodnick PJ, Amer J Psychiatry, 1/1/2013
• Bipolar depression: A review of randomized clinical trials  
  Goodnick PJ, Expert Opin Pharmacother, 1/1/2007
• Selegiline transdermal system in depression  
  Goodnick PJ, Expert Opin Pharmacother, 1/1/2007
• Use of anticonvulsants in the treatment of bipolar mania  
  Goodnick PJ, Expert Opin Pharmacother, 1/1/2006
• Higher than Physicians Desk Reference (US) doses on atypical antipsychotics  
  Goodnick PJ, Expert Opin Drug Saf, 1/1/2005
• The effectiveness of St John’s Wort in major depressive disorder A naturalistic phase 2 followup in which nonresponders were provided alternative medication  
  Gelenberg AJ, Shelton RC, Chris-Christoph P, Keller MB, Dunner DL, Hirschfeld RM, Thase ME, Russell JM, Lydiard RB, Gallop RJ, Todd L, Hellerstein DJ, Goodnick PJ, Kei..., J Clin Psychiatry, 1/1/2004
• Predictors of response in mood disorders  
  Esposito K, Goodnick P, Psychiatric Clinics of N America, 1/1/2003
• A Consensus Manual for the Primary Care and Management of Chronic Fatigue Syndrome  
  Kaufman KR, Goodnick PJ, 1/1/2002
• Psychotropic drugs and the ECG: focus on the QTc interval  
  Goodnick PJ, Jerry J, Parra F, Exp Opin Pharmacotherapy, 1/1/2002
• Antipsychotics: Impact on prolactin levels  
  Goodnick PJ, Rodriguez L, Santana O, Exp Opin Pharmacotherapy, 1/1/2002
• Aripiprazole: Profile on safety and efficacy  
  Goodnick PJ, Jerry J, Exp Opin Pharmacotherapy, 1/1/2002
• Update on depression and diabetes; use of psychotropics in diabetes mellitus  
  Goodnick PJ, Annals of Clinical Psychiatry, 1/1/2001
• The relationship of numbing to alexithymia, apathy, and depression  
  Ramirez SM, Glover H, Ohlde C, Mercer R, Goodnick P, Hamlin C, Perez-Rivera MI, Psychol Reports, 1/1/2001
• Use of olanzapine in non-psychotic psychiatric disorders  
  Goodnick P, Barrios CA, Expert Opinion on Pharmacotherapy, 1/1/2001
• John=s Wort in major depression: A multicenter, randomized placebo-controlled trial  
  Goodnick PJ, JAMA, 1/1/2001
• Cognitive Psychotherapy Toward a New Millenium  
  Johnson SL, Meyer B, Winters RW, Sandrow D, Goodnick P, 1/1/2001
• Rapid cycling bipolar disorder  
  Barrios C, Chaudhry T, Goodnick PJ, Expert Opinion on Pharmacotherapy, 1/1/2001
• Antipsychotic medication: Effects on regulation of glucose and lipids  
  Kato M, Goodnick PJ, Expert Opinion on Pharmacotherapy, 1/1/2001
• Vagus nerve stimulation in depression  
  Goodnick PJ, Rush AJ, George MS, Marangell LB, Sackeim HA, Expert Opinion on Pharmacotherapy, 1/1/2001
• Ziprasidone: Profile on safety  
  Goodnick PJ, Expert Opinion on Pharmacotherapy, 1/1/2001
• Nefazodone treatment of adolescent depression: Response and biochemistry  
  Goodnick PJ, Jorge CM, Hunter T, Kumar A, 1/1/2000
• The use of nimodipine in the treatment of mood disorders  
  Goodnick P, Bipolar Disorders, 1/1/2000
• Sertraline in diabetic neuropathy: Response and Biology  
  Goodnick PJ, Mendosa L, Kumar A, Freund B, DeVane CL, Psychosomatic Med, 1/1/2000
• Nefazodone in diabetic neuropathy  
  Goodnick PJ, Breakstone K, Kumar A, Freund B, DeVane CL, Psychosomatic Med, 1/1/2000
• Join now to see all

Books/Book Chapters

• Bipolar Medications: Mechanisms of Action 
  Chapter: Calcium channel blockers in bipolar disorder 
  Page 389.0 - 405.0Goodnick PJ, Benitez AEditors: Manji HK, Bowden CL, & Belmaker RH.APPI, New York2000
• Mania: Clinical & Research Perspectives 
  Chapter: Psychotherapy 
  Page 363.0 - 381.0McAlpin CA, Goodnick PJEditors: Goodnick PJ.APPI, Washington and London1998
• Mania: Clinical & Research Perspectives 
  Chapter: Novel Antipsychotics 
  Page 319.0 - 336.0Frankenburg FR, Zanarini MC, Goodnick PJEditors: Goodnick PJ.APPI, Washington and London1998
• Mania: Clinical & Research Perspectives 
  Chapter: Calcium Antagonists and Newer Anticonvulsants 
  Page 337.0 - 362.0Currier B, Goodnick PJEditors: Goodnick PJ.APPI, Washington and London1998
• Mania: Clinical & Research Perspectives 
  Chapter: Lithium 
  Page 241.0 - 262.0Ownby R, Goodnick PJEditors: Goodnick PJ.APPI, Washington and London1998
• Mania: Clinical & Research Perspectives 
  Chapter: Catecholamines 
  Page 119.0 - 134.0Buki V, Goodnick PJEditors: Goodnick PJ.APPI, Washington and London1998
• Mania: Clinical & Research Perspectives 
  Chapter: Serotonin 
  Page 103.0 - 118.0Goodnick PJEditors: Goodnick PJ.APPI, Washington and London1998
• Mania: Clinical & Research Perspectives 
  Chapter: Creativity and mood disorder 
  Page 11.0 - 35.0Carreno TB, Goodnick PJEditors: Goodnick PJ.APPI, Washington and London1998
• Current Psychiatric Therapy II 
  Chapter: Chronic fatigue syndrome 
  Page 552.0 - 557.0Goodnick PJ, Jorge CMEditors: Dunner DL.W.B. Saunders, Philadelphia1997
• Predictors of Response in Mood Disorders 
  Chapter: Monoamine oxidase inhibitors 
  Page 37.0 - 55.0Ownby R, Goodnick PJEditors: Goodnick PJ.APPI, Washington and London1996
• Predictors of Response in Mood Disorders 
  Chapter: New Antidepressants 
  Page 57.0 - 94.0Goodnick PJEditors: Goodnick PJ.APPI, Washington and London1996
• Chronic Fatigue and Related Immune Deficiency Syndromes 
  Chapter: Psychotropic treatment of chronic fatigue and related syndromes 
  Page 131.0 - 159.0Goodnick PJ, Sandoval REditors: Goodnick PJ, Klimas, N.American Psychiatric Press, Washington & London1993
• Chronic Fatigue and Related Immune Deficiency Syndromes 
  Chapter: Treatment of chronic fatigue syndrome and related disorders: Immunological approaches 
  Page 109.0 - 129.0Sandoval R, Goodnick PJEditors: Goodnick PJ, Klimas, N.American Psychiatric Press, Washington & London1993
• Biological Psychiatry 
  Chapter: Lithium potentiation of bupropion and fluoxetine: Theory & Practice 
  Page 353.0 - 356.0Goodnick PJEditors: Racagni G.Elsevier Science Publishers, New York1991
• New Directions in Affective Disorders 
  Chapter: Serotonin and catecholamines in lithium treatment 
  Page 138.0 - 141.0Goodnick PJEditors: B Lerer, S Gershon.Springer-Verlag1989
• Modern Lithium Therapy 
  Chapter: Terminating treatment 
  Page 115.0 - 117.0Goodnick PJEditors: FN Johnson.MTP Press Ltd, London1987
• Psychiatry Letter 
  Chapter: Manic-depression update 1986 
  Page 29.0 - 34.0Fieve RR, Goodnick PJEditors: Davies RK, Gold MS.1986
• Metal Ions in Neurology and Psychiatry 
  Chapter: The use of lithium and experimental rubidium in psychiatry 
  Page 107.0 - 120.0Fieve RR, Jamison K, Goodnick PJEditors: S Gabay, J Harris, BT Ho.Alan R Liss Inc, New York1985
• Handbook of Neurochemistry, Volume 9 
  Chapter: Lithium 
  Page 103.0 - 149.0Goodnick PJ, Gershon SEditors: A Lajtha.Plenum Press, New York1985
• Clinical Geriatric Psychopharmacology 
  Chapter: Dementia and memory loss in the elderly 
  Page 171.0 - 186.0Goodnick PJ, Gershon S, Salzman CEditors: C Salzman.McGraw-Hill, New York1984
• Neurobiology of Cerebrospinal Fluid II 
  Chapter: Acetylcholinesterase in neuropsychiatric disorders 
  Page 197.0 - 203.0Davis KL, Goodnick PJEditors: JH Wood.Plenum Press, New York1983
• Aging of the Brain 
  Chapter: Chemotherapy of cognitive diorders 
  Page 349.0 - 361.0Goodnick PJ, Gershon SEditors: D Samuel, S Algeri, S Gershon, VE Grimm, G Toffero.Raven Press, New York1983
• Critical Issues in Psychiatry 
  Chapter: Toward a resolution of clinical and basic science issues 
  Page 49.0 - 77.0Fieve RR, Goodnick PJEditors: JO Cavenar Jr, HKH Brodie.JB Lippincott Company, Philadelphia1983
• Alzheimer`s Disease: A Report of Progress 
  Chapter: A dose-response study of lecithin in the treatment of Alzheimer`s disease 
  Page 379.0 - 383.0Pomara N, Goodnick PJ, Brinkman S, Domino E, Gershon SEditors: S Corkin, KL Davis, J Growdon, E Usdin, RJ Wurtman.Raven Press, New York1982
• Join now to see all

Abstracts/Posters

• Use of antipsychotic medication in treatment & prophylaxis of bipolar disorder
  Goodnick PJ, International Journal of Neuropsychopharmacology, 1/1/1998
• Calcium channel inhibitors in mania
  Goodnick P, New Directions in Affective Disorders, Jeursalem, Israel, 1/1/1995
• Differentiation of chronic fatigue syndrome and depression
  Goodnick P, New Directions in Affective Disorders, Jeursalem, Israel, 1/1/1995
• Response to selective serotonin reuptake inhibitors and non-tricyclic antidepressants
  Goodnick PJ, Don YM, Henry JH, 1995 CME and Proceedings Summary, 148th Annual Meeting, American Psychiatric Association, Miami Beach, 1/1/1995
• Continuous Clinical Case Conference [Chronic Fatigue Syndrome]
  Goodnick PJ, Demitrack MA, Eisman G, Klimas NG, Ratzan K, Brickman AL, Feldhammer T, Heiken G, Spellman CBR, 1995 CME and Proceedings Summary, 148th Annual Meeting, American Psychiatric Association, Miami Beach, 1/1/1995
• Treatment of depression in patients with diabetes mellitus
  Goodnick PJ, Southern Medical Journal, SMA Annual Meeting, Kansas City, MO, 1/1/1995
• Differentiation of chronic fatigue syndrome from depression
  Jorge C, Goodnick PJ, Southern Medical Journal, SMA Annual Meeting, Kansas City, MO, 1/1/1995
• Relationship of response to verapamil in mania to changes in plasma calcium and magnesium
  Goodnick PJ, Southern Medical Journal, SMA Annual Meeting, Kansas City, MO, 1/1/1995
• Depression in diabetes mellitus
  Goodnick PJ, Henry JH, Buki V, 1994 CME and Proceedings Summary, 147th Annual Meeting, American Psychiatric Association, Philadelphia, PA, 1/1/1994
• Update on lithium and calcium channel inhibitors
  Goodnick PJ, Currier B, 1994 CME and Proceedings Summary, 147th Annual Meeting, American Psychiatric Association, Philadelphia, PA, 1/1/1994
• Antidepressant mechanism of action & symptom response in chronic fatigue syndrome
  Goodnick PJ, Biological Psychiatry, Society of Biological Psychiatry, 1/1/1993
• Bupropion treatment of fluoxetine-resistant chronic fatigue syndrome
  Goodnick PJ, Sandoval R, Brickman A, Klimas N, Biological Psychiatry, 1/1/1992
• Blood levels and bupropion response
  Goodnick PJ, Biological Psychiatry, 1/1/1992
• Fluoxetine blood levels and clinical response
  Goodnick PJ, Biological Psychiatry, 1/1/1992
• Acute and long-term bupropion therapy: response and side effects
  Goodnick P, Annals of Clinical Psychiatry, AACP 1991 Meeting, 1/1/1991
• Subclinical mood symptoms in substance abuse
  Goodnick P, American Psychopathological Association annual meeting, New York, New York, 1/1/1988
• The role of serotonin and catecholamines in lithium prophylaxis: Human studies
  Goodnick P, International Conference on New Directions in Affective Disorders, Jerusalem, Israel, 1/1/1987
• Interepisode major symptoms in affective disorders
  Goodnick P, International Conference on New Directions in Affective Disorders, Jerusalem, Israel, 1/1/1987
• Subclinical symptoms in affective disorders
  Goodnick P, International Conference on New Directions in Affective Disorders, Jerusalem, Israel, 1/1/1987
• Lithium level effect on interepisode major and subclinical symptoms of affective disorder
  Goodnick P, International Conference on New Directions in Affective Disorders, Jerusalem, Israel, 1/1/1987
• Lithium withdrawal effect on the 5HTP and clonidine tests
  Goodnick P, New Research, A.P.A. Annual meeting, Washington, DC, 1/1/1986
• Double-blind treatment of major depression with fluoxetine: Use of pattern analysis and relation of HDRS to CGI changes
  Goodnick P, Annual New Clinical Drug Evaluation Unit (NCDEU) meeting of NIMH, Key Biscayne, FL, 1/1/1986
• Clinical, biological, and neuroendocrine effects of lithium discontinuation
  Goodnick P, A.C.N.P. annual meeting, Washington, DC, 1/1/1986
• Pattern analysis of antidepressant response to fluoxetine: A replication
  Goodnick P, A.C.N.P. annual meeting, Washington, DC, 1/1/1986
• Effect of long term lithium prophylaxis on the 5-hydroxytryptophan-induced cortisol response in bipolar patients
  Goodnick P, Society of Biological Psychiatry Annual Meeting, Dallas, TX, 1/1/1985
• Join now to see all

Lectures

• Advances in Psychopharmacology, Strategies in Treatment and Adherence 
  1/1/2010
• Update on Use of Atypical Antipsychotics in Bipolar Disorder and Schizophrenia 
  Morristown Medical Center, Morristown, NJ - 1/1/2006
• Advances in Use of Atypical Antipsychotics in Mood Disorders 
  Buffalo Psychiatric Center - 1/1/2006
• Algorithms in Bipolar Disorder and Schizophrenia 
  SUNY Albany Medical Center - 1/1/2006
• Bipolar Depression 
  University of Florida Department of Psychiatry - 1/1/2006
• Vagus nerve stimulation in depression 
  Department of Psychiatry, University of Iowa School of Medicine, Iowa City, IA, 2001 ; Department of - 1/1/2002
• The role of dopamine in depression 
  Department of Psychiatry, University of South Florida, Tampa, FL - 1/1/2002
• Diabetes mellitus and psychotropic medication 
  Masters in Psychiatry, University of Miami, Miami Beach, FL - 1/1/2001
• Depression and Medical Illness 
  Lexington, KY - 1/1/2001
• Psychosocial interventions in bipolar disorders 
  Atlanta, GA - 1/1/2001
• Psychotropic medication and impact on glucose & lipids 
  Department of Psychiatry, University of Iowa School of Medicine, Iowa City, IA - 1/1/2001
• Chronic fatigue syndrome: Differentiation from depression 
  Department of Psychiatry, New Brunswick, NJ - 1/1/2000
• Atypical Antipsychotics in Mood Disorders 
  Miami, FL - 1/1/2000
• St Johns Wort & SAMe: Effective for Mood Disorders? 
  Masters of Psychiatry, University of Miami, Key West, FL - 1/1/2000
• Use of antidepressants and their effects on sleep and anxiety disorders 
  University of Nebraska School of Medicine - 1/1/2000
• New treatments in mood disorders 
  Flower Hospital, Perrysburg, Ohio - 1/1/2000
• Sleep and Effects of Antidepressants 
  1/1/1999
• Emerging Issues in Bipolar Disorder 
  Miami, FL - 1/1/1999
• New Antidepressants in development 
  Masters of Psychiatry, University of Miami, Key West, FL - 1/1/1999
• Current treatment for panic and anxiety diorders 
  San Francisco, CA - 1/1/1999
• Panic, anxiety, sleep disorders 
  San Francisco, CA - 1/1/1999
• Chronic Fatigue Syndrome Roundtable 
  UCSF, San Francisco, CA - 1/1/1999
• Chronic Fatigue Syndrome: Is it depression? 
  Torrence, CA - 1/1/1999
• Use of antidepressants in pain syndromes 
  Department of Anesthesiology, University of Miami School of Medicine - 1/1/1999
• Effects of antidepressants on sleep and use in anxiety disorders 
  University of Texas, Southwestern Medical Center, Dallas, Texas - 1/1/1999
• Join now to see all